Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week.
Gaschwald

  • Heptares is now collaborating with Daichii Sankyo in a €11M deal for the biotech’s pain program
  • Greenergy, Europe’s largest manufacturer of biodiesel from waste, forged a collaboration with Bio-on to explore producing PHAs bioplastic from glycerol

Marcel Derweduwen

  • Allergan‘s IBD drug has been linked to deaths in patients without gallbladders

belizar

  • After installing its first female CEO, GSK has opted to pay her less than her predecessor
  • Researchers at the Turku Centre for Biotechnology have discovered a link between cancer and autism
  • VIB has reported a new toxic pathway for protein aggregates in neurodegenerative disease, which could provide an alternative target as efforts in Alzheimer’s hit road block after road block

Happy Friday!

c6t6_inwcaahdbu_1024


Images from belizar, Frank Gaertner, Gaschwald, Marcel Derweduwen / shutterstock.com

ADVERTISEMENT
Previous post

This Polish Biotech is developing More Effective and Safer Super-Generics

Next post

Can this British Biotech Overcome Failure buying drugs from AstraZeneca?